@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAI15S8HNzrrusLdDaKuLpxco4bkol9nrPcKj_xHCKOy8> .
@prefix sub: <http://purl.org/np/RAI15S8HNzrrusLdDaKuLpxco4bkol9nrPcKj_xHCKOy8#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}
sub:assertion {
   sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  sub:version prov:value 1 .
  rdf:object ns1:C0006802 "CMR" ;
    ns1:C0021368 "inflammation" ;
    ns1:C0026820 "contractile" ;
    ns1:C0205210 "clinical" ;
    ns1:C0229671 "serum" ;
    ns1:C0237820 "recovery" ;
    ns1:C0277785 "dysfunction" ;
    ns1:C0301630 "reduction" ;
    ns1:C0392756 "reduction" ;
    ns1:C0456962 "rapid" ;
    ns1:C0522501 "marked" ;
    ns1:C1293152 "reduction" ;
    ns1:C1546774 "serum" ;
    ns1:C1550100 "serum" ;
    ns1:C1555688 "recovery" ;
    ns1:C1705938 "based" ;
    ns1:C1706089 "marked" ;
    ns1:C2004454 "recovery" ;
    ns1:C2986411 "improvement" ;
    ns1:C3272565 "clinical" ;
    ns1:C3887504 "dysfunction" ;
    ns1:C3887505 "dysfunction" ;
    ns1:C4050307 "CMR" ;
    ns1:C4050308 "CMR" ;
    ns1:C4551656 "reduction" .
  rdf:predicate ns2:TRIPLE_UID:ezgtl5fj-TRIPLE-ABSTRACT-1 "result" .
  rdf:subject ns1:C0011777 "dexamethasone" ;
    ns1:C0087111 "Treatment" ;
    ns1:C0245109 "anakinra" ;
    ns1:C1522428 "recombinant interleukin-1" ;
    ns1:C1533734 "Treatment" ;
    ns1:C1705169 "Treatment" ;
    ns1:C3161471 "Treatment" ;
    ns1:C3538994 "Treatment" ;
    ns1:C3887704 "Treatment" ;
    ns1:C4543207 "receptor antagonist" ;
    ns1:C4721408 "receptor antagonist" ;
    ns1:C5399721 "receptor antagonist" .
  rdfs:Triple-UID ns3:TRIPLE_UID:ezgtl5fj-TRIPLE-ABSTRACT-1 "ezgtl5fj-TRIPLE-ABSTRACT-1" .
  rdfs:sentence rdfs:label "Treatment with the recombinant interleukin-1 (IL)-1) receptor antagonist anakinra and dexamethasone resulted in rapid clinical improvement, reduction in serum inflammatory markers and a marked recovery in CMR-based markers of inflammation and contractile dysfunction." .
  rdfs:triple rdfs:label "Treatment with the recombinant interleukin-1 ( IL)-1 ) receptor antagonist anakinra and dexamethasone resulted in rapid clinical improvement , reduction in serum inflammatory markers and a marked recovery in CMR - based markers of inflammation and contractile dysfunction" .
}
sub:provenance {
   sub:assertion prov:generatedAtTime "2021-07-25T21:47:47.785502"^^xsd:dateTime .
}
sub:pubInfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
    npx:hasSignature "gsItPbCyh5MkFvYHgcYXjZpuDNH5gl/5DpdIBw2nTL94DPHErq9+Zv9d077kAQYYJMZCR632fQGF/S9Iik6aCFIoBqf4DOE3z2QbDf/cRB7LUw79/3pto0uBX7DsjXKgsSOOJQ62ihKIwUVoHhv9tweDgUxs6tHBg68aCKYcJ9c=" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2021-07-25T21:47:47.785502"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}